• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内核层与外丛状层之间边界平滑预示着分支状视网膜静脉阻塞的黄斑水肿复发较少。

Smooth borders between inner nuclear layer and outer plexiform layer predict fewer macular edema recurrences in branch retinal vein occlusion.

机构信息

Department of Ophthalmology, Shinseikai Toyama Hospital, Imizu, Toyama, Japan.

Department of Ophthalmology, Aichi Medical University, Nagakute, Aichi, Japan.

出版信息

Sci Rep. 2021 Aug 6;11(1):15987. doi: 10.1038/s41598-021-95501-w.

DOI:10.1038/s41598-021-95501-w
PMID:34362985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8346557/
Abstract

We hypothesized the smoothness of the border between the inner nuclear layer (INL) and outer plexiform layer (OPL) associates with the frequency of macular edema (ME) recurrences secondary to branch retinal vein occlusion (BRVO). Thirty-seven consecutive eyes with BRVO treated with anti-vascular endothelial growth factor (VEGF) injections at 1-year follow-up were included. We manually traced the border between the INL and OPL within the 1.5-mm vertical line from the fovea on optical coherence tomography (OCT) images at the initial visit. The jagged ratio (JR), the border length divided by the spline curve length, was calculated. We performed univariate and multivariate regression analyses, including JR, patient characteristics, number of cystoid spaces in the INL, INL area, and outer retina area. Multivariate regression analysis showed JR significantly correlates with the total number of anti-VEGF injections (P < 0.0001). Moreover, the mean JR was significantly lower in the nine eyes receiving two or fewer injections than in the 28 eyes receiving three or more injections (1.02 ± 0.01 vs. 1.13 ± 0.06, P < 0.0001). A smooth border between the INL and the OPL on OCT images at the initial visit may be a biomarker for fewer ME recurrences in eyes with BRVO.

摘要

我们假设内核层(INL)和外丛状层(OPL)之间边界的平滑度与分支视网膜静脉阻塞(BRVO)继发的黄斑水肿(ME)复发频率有关。在 1 年的随访中,对 37 只接受抗血管内皮生长因子(VEGF)注射治疗的 BRVO 连续眼进行了研究。我们在初始就诊时的光学相干断层扫描(OCT)图像上,于黄斑中心凹下 1.5mm 垂直线内手动追踪 INL 和 OPL 之间的边界。计算锯齿比(JR),即边界长度除以样条曲线长度。我们进行了单变量和多变量回归分析,包括 JR、患者特征、INL 中囊状空间的数量、INL 面积和外视网膜面积。多变量回归分析表明,JR 与抗 VEGF 注射的总次数显著相关(P<0.0001)。此外,接受 2 次或更少注射的 9 只眼的平均 JR 明显低于接受 3 次或更多注射的 28 只眼(1.02±0.01 与 1.13±0.06,P<0.0001)。在初始就诊时的 OCT 图像上,INL 和 OPL 之间边界平滑可能是 BRVO 眼 ME 复发次数较少的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8399/8346557/df37843c65cc/41598_2021_95501_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8399/8346557/6037a0495193/41598_2021_95501_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8399/8346557/a516af88a358/41598_2021_95501_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8399/8346557/192d21e496aa/41598_2021_95501_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8399/8346557/e5de5c13f2dd/41598_2021_95501_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8399/8346557/9cb91a75eee6/41598_2021_95501_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8399/8346557/df37843c65cc/41598_2021_95501_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8399/8346557/6037a0495193/41598_2021_95501_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8399/8346557/a516af88a358/41598_2021_95501_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8399/8346557/192d21e496aa/41598_2021_95501_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8399/8346557/e5de5c13f2dd/41598_2021_95501_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8399/8346557/9cb91a75eee6/41598_2021_95501_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8399/8346557/df37843c65cc/41598_2021_95501_Fig6_HTML.jpg

相似文献

1
Smooth borders between inner nuclear layer and outer plexiform layer predict fewer macular edema recurrences in branch retinal vein occlusion.内核层与外丛状层之间边界平滑预示着分支状视网膜静脉阻塞的黄斑水肿复发较少。
Sci Rep. 2021 Aug 6;11(1):15987. doi: 10.1038/s41598-021-95501-w.
2
Impact of anti-VEGF therapy on distinctive retina layers in patients with macular edema secondary to branch retinal vein occlusion.抗 VEGF 治疗对分支视网膜静脉阻塞继发黄斑水肿患者不同视网膜层的影响。
BMC Ophthalmol. 2023 May 25;23(1):235. doi: 10.1186/s12886-023-02981-7.
3
[Correlation between photoreceptor layer and visual acuity in eyes with persistent cystoid macular edema secondary to branch retinal vein occlusion].[视网膜分支静脉阻塞继发持续性黄斑囊样水肿眼中光感受器层与视力的相关性]
Zhonghua Yan Ke Za Zhi. 2010 Nov;46(11):1006-10.
4
Longitudinal analysis of the structural pattern of pseudophakic cystoid macular edema using multimodal imaging.使用多模态成像对人工晶状体眼黄斑囊样水肿的结构模式进行纵向分析。
Graefes Arch Clin Exp Ophthalmol. 2016 Jan;254(1):43-51. doi: 10.1007/s00417-015-3000-8. Epub 2015 Apr 12.
5
Predicting recurrences of macular edema due to branch retinal vein occlusion during anti-vascular endothelial growth factor therapy.预测抗血管内皮生长因子治疗期间分支视网膜静脉阻塞引起的黄斑水肿复发。
Graefes Arch Clin Exp Ophthalmol. 2020 Jan;258(1):49-56. doi: 10.1007/s00417-019-04495-9. Epub 2019 Nov 15.
6
Foveal photoreceptor layer in eyes with persistent cystoid macular edema associated with branch retinal vein occlusion.伴有视网膜分支静脉阻塞相关持续性黄斑囊样水肿的眼中的中央凹光感受器层
Am J Ophthalmol. 2008 Feb;145(2):273-280. doi: 10.1016/j.ajo.2007.09.019. Epub 2007 Nov 28.
7
Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion.光学相干断层扫描(OCT)引导下贝伐单抗治疗视网膜静脉阻塞所致黄斑水肿的长期随访
Graefes Arch Clin Exp Ophthalmol. 2009 Dec;247(12):1635-41. doi: 10.1007/s00417-009-1151-1. Epub 2009 Jul 26.
8
Disorganization of the Retinal Inner Layers after Anti-VEGF Treatment for Macular Edema due to Branch Retinal Vein Occlusion.视网膜分支静脉阻塞所致黄斑水肿抗VEGF治疗后视网膜内层的紊乱
Ophthalmologica. 2018;240(4):229-234. doi: 10.1159/000490809. Epub 2018 Aug 8.
9
Correlation between macular vessel density and number of intravitreal anti-VEGF agents for macular edema associated with branch retinal vein occlusion.与分支视网膜静脉阻塞相关的黄斑水肿的黄斑血管密度与玻璃体内抗 VEGF 药物数量之间的相关性。
Sci Rep. 2019 Nov 8;9(1):16388. doi: 10.1038/s41598-019-52732-2.
10
Neuroretinal atrophy following resolution of macular oedema in retinal vein occlusion.视网膜静脉阻塞黄斑水肿消退后的神经视网膜萎缩。
Br J Ophthalmol. 2019 Jan;103(1):36-42. doi: 10.1136/bjophthalmol-2017-311614. Epub 2018 Mar 6.

本文引用的文献

1
The randomized ZIPANGU trial of ranibizumab and adjunct laser for macular edema following branch retinal vein occlusion in treatment-naïve patients.随机 ZIPANGU 试验:雷珠单抗联合激光治疗初治的视网膜分支静脉阻塞继发黄斑水肿
Sci Rep. 2021 Jan 12;11(1):551. doi: 10.1038/s41598-020-79051-1.
2
ANGIOGRAPHIC RISK FACTORS FOR RECURRENCE OF MACULAR EDEMA ASSOCIATED WITH BRANCH RETINAL VEIN OCCLUSION.与分支视网膜静脉阻塞相关的黄斑水肿复发的血管造影危险因素。
Retina. 2021 Jun 1;41(6):1219-1226. doi: 10.1097/IAE.0000000000003026.
3
Predicting recurrences of macular edema due to branch retinal vein occlusion during anti-vascular endothelial growth factor therapy.
预测抗血管内皮生长因子治疗期间分支视网膜静脉阻塞引起的黄斑水肿复发。
Graefes Arch Clin Exp Ophthalmol. 2020 Jan;258(1):49-56. doi: 10.1007/s00417-019-04495-9. Epub 2019 Nov 15.
4
Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion: A Randomized Clinical Trial.雷珠单抗、阿柏西普与贝伐单抗玻璃体内注射治疗视网膜中央静脉阻塞继发黄斑水肿的临床疗效:一项随机临床试验
JAMA Ophthalmol. 2019 Nov 1;137(11):1256-1264. doi: 10.1001/jamaophthalmol.2019.3305.
5
Collateral Vessels in Branch Retinal Vein Occlusion: Anatomic and Functional Analyses by OCT Angiography.视网膜分支静脉阻塞中的侧支血管:光学相干断层扫描血管造影的解剖学和功能分析
Ophthalmol Retina. 2019 Sep;3(9):767-776. doi: 10.1016/j.oret.2019.04.015. Epub 2019 Apr 18.
6
Loss of Peak Vision in Retinal Vein Occlusion Patients Treated for Macular Edema.视网膜静脉阻塞患者治疗黄斑水肿后视力峰值丧失。
Am J Ophthalmol. 2019 Sep;205:17-26. doi: 10.1016/j.ajo.2019.03.029. Epub 2019 Apr 4.
7
Human Parafoveal Capillary Vascular Anatomy and Connectivity Revealed by Optical Coherence Tomography Angiography.光学相干断层扫描血管造影术揭示的人周边凹毛细血管血管解剖结构和连通性。
Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):3858-3867. doi: 10.1167/iovs.18-24710.
8
INJECTION FREQUENCY OF AFLIBERCEPT VERSUS RANIBIZUMAB IN A TREAT-AND-EXTEND REGIMEN FOR CENTRAL RETINAL VEIN OCCLUSION: A Randomized Clinical Trial.阿柏西普与雷珠单抗治疗并延长方案治疗中心性视网膜静脉阻塞的注射频率:一项随机临床试验。
Retina. 2019 Jul;39(7):1370-1376. doi: 10.1097/IAE.0000000000002171.
9
Correlation between reduction in macular vessel density and frequency of intravitreal ranibizumab for macular oedema in eyes with branch retinal vein occlusion.分支静脉阻塞性黄斑水肿患者玻璃体内注射雷珠单抗治疗后黄斑血管密度与注射频率的相关性。
Br J Ophthalmol. 2019 Jan;103(1):72-77. doi: 10.1136/bjophthalmol-2017-311499. Epub 2018 Mar 15.
10
Disorganization of the Retinal Inner Layers as a Predictor of Visual Acuity in Eyes With Macular Edema Secondary to Vein Occlusion.视网膜内层结构紊乱作为静脉阻塞继发黄斑水肿患者视力的预测指标
Am J Ophthalmol. 2017 Oct;182:160-167. doi: 10.1016/j.ajo.2017.08.005. Epub 2017 Aug 22.